FDA-Inspected Site

Mayon'S Pharmaceuticals Pvt Ltd

1 FDA inspection is on record for Mayon'S Pharmaceuticals Pvt Ltd in Nagpur, India.

483· Form 483 issued

Nagpur, India · Last updated July 11, 2026

Overview

  • 1 FDA inspection is on record.
  • 1 inspection produced a Form 483.
  • The most recent recorded inspection date is 2020-02-20.

At a glance

Inspections

1

Form 483s

1

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
17 Feb 2020 – 20 Feb 2020Human DrugsWLView 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

20 Feb 2020
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Andrew K Haack

20 Feb 2020
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Andrew K Haack

20 Feb 2020
21 CFR 211.165(a)

Testing and release for distribution

Cited by Andrew K Haack

20 Feb 2020
21 CFR 211.166(c)(1)

Homeopathic drugs, assessment of stability

Cited by Andrew K Haack

20 Feb 2020
21 CFR 211.180(e)

Records reviewed annually

Cited by Andrew K Haack

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(a)Cited across public-safe Form 483 observations1x
21 CFR 211.166(c)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)Cited across public-safe Form 483 observations1x
21 CFR 211.188Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Mayon'S Pharmaceuticals Pvt Ltd's 1 Form 483

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat